Home > Boards > US Listed > Biotechs > BrainStorm Cell Therapeutics Inc. (BCLI)

The lesson being "read first".

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
goodJohnhunting Member Profile
Member Level 
Followed By 33
Posts 1,294
Boards Moderated 1
Alias Born 08/27/00
160x600 placeholder
BrainStorm’s NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled GlobeNewswire Inc. - 10/11/2019 1:00:00 AM
BrainStorm Announces Notice of US Patent Allowance for NurOwn® Cellular Therapeutic Technology Platform GlobeNewswire Inc. - 10/7/2019 8:04:26 AM
BrainStorm Cell Therapeutics to Present NurOwn® Phase 2 Biomarker Data at North East Amyotrophic Lateral Sclerosis (NEALS) 1... GlobeNewswire Inc. - 10/2/2019 6:45:00 AM
BrainStorm Cell Therapeutics Announces Support for FDA Guidelines on ALS Drug Development GlobeNewswire Inc. - 9/27/2019 4:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 8:01:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 8:01:32 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/9/2019 8:01:03 AM
BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financi... GlobeNewswire Inc. - 9/9/2019 1:00:00 AM
BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress GlobeNewswire Inc. - 9/6/2019 1:50:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/3/2019 6:01:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2019 5:03:19 PM
Prospectus Filed Pursuant to Rule 424(b)(1) (424b1) Edgar (US Regulatory) - 8/30/2019 5:02:28 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/16/2019 5:18:25 PM
BrainStorm Announces Financial Results for the Second Quarter of 2019 and Provides a Corporate Update GlobeNewswire Inc. - 8/13/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 6:05:47 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/9/2019 5:10:20 PM
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update GlobeNewswire Inc. - 8/5/2019 1:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/2/2019 5:02:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 9:30:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/26/2019 5:04:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 5:04:06 PM
Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study GlobeNewswire Inc. - 7/2/2019 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:03:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/11/2019 5:03:07 PM
BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting GlobeNewswire Inc. - 5/31/2019 1:00:00 AM
goodJohnhunting Member Level  Monday, 04/01/19 05:11:35 PM
Re: condoe3 post# 2499
Post # of 2560 
The lesson being "read first".



Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist